Groisman EA, Kayser J, Soncini FC. 24 (6), 1243–1244 (1997). 28, 402–404 (1962). Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin modifying enzyme. resistance to these antibiotics can occur during therapy to treat Enterobacter cloacae. Colicins, bacteriocins produced by E. coli, were found in 30–50% of the strains isolated from human hosts and are often referred to as a virulence factor. 14 (1), 45–47 (2008). Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a university hospital. They can be both aerobic and anaerobic. In colicins, the central domain comprises about 50% of the protein and is involved in the recognition of specific cell surface receptors. Abstract and Introduction Abstract. Journal of Clinical Microbiology. The strains revealed that E. cloacae can be used as a biological control agent for Pythium ultimum. The majority of organisms isolated from contaminated platelet components are skin commensal bacteria, which enter into the needle during venipuncture. 39, 168–172 (2012). Although relatively susceptible to disinfection and desiccation when dried on a surface, E. cloacae can be a challenging microorganism to mitigate in solution. International Journal of Antimicrobial Agents. Antimicrobial Agents and Chemotherapy. However, it may be an opportunistic pathogen and has an increasing importance in hospital-acquired infections (intensive care units, emergency units, urology). Humans are only endangered by the Enterobacter … The management of this sort of infection is complicated because it has resistance to many types of antibiotics. reported an outbreak in a neonatal intensive care unit with nine deaths, and in 2003, Kuboyama et al. This organism affects mostly the vulnerable age groups such as the elderly and the young and can cause prolonged hospitalization in the intensive care unit (ICU) (5). Although this organism is mainly a pathogen for human and causes disease, Enterobacter cloacae have been used as a biological control for plant disease such as the seed-rotting oomycete in Pythium ultimum and used to control insect pests on mulberry leaves and suppress disease (3). A proposed genus Enterobacter.  The differentiation of these subspecies is based on their particular properties and biochemical tests. Journal of Clinical Microbiology. Bratu S, Landman D, Alam M, Tolentino E, Quale J. PLoS One3, e3018 (2008). Regulation of polymyxin resistance and adaptation to low-Mg2+ environments. In order to do do so, it requires menaquinone, which acts as an electron carrier. Studies have shown that Enterobacter cloacae has caused an outbreak of infections in many hospital burn centers. Journal of Medical Case Reports. E. c. subsp. Davin-Regli A, Bosi C, Charrel R et al. 4th generation antibiotics like Cefpirome can usually maintained their activity against the strains of Enterobacter which are resistant to the third generation of cephalosporins. Vol. The suspected food was eaten during lunch. Journal of Clinical Microbiology.36, 3085–3087 (1998). Enterobacter sakazakii has no importance as an enteric pathogen, but it is a rare cause of neonatal meningitis and sepsis; it occurs in the environment and in food. Enterobacter agglomerans (Beijerinck) comb. In this case, it is transcribed from its own promoter under constitutive regulation. Guidance for control of infections with carbapenem-resistant or carbapenemase producing Enterobacteriaceae in acute care facilities. hormaechei and E. hormaechei subsp. International Journal of Antimicrobial Agents. and was formerly called Erwinia nimipressuralis, which was isolated from nonclinical sources (e.g., elm trees with a disease called wet wood). Jun 2007; 69(10):47-51. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17583296&ordinalpos=18&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum, (7) Juanjuan D, Zhiyong Z, Xiaoju L, Yali X, Xihai Z, Zhenzhen L. “Retrospective analysis of bacteremia because of Enterobacter cloacae compared with Escherichia coli bacteremia.” April 2007; 61(4):583-8. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17394432&ordinalpos=40&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum, (8) Kanemitsu K, Endo S, Oda K, Saito K, Kunishima H, Hatta M, Inden K, Kaku M. “An increased incidence of Enterobacter cloacae in a cardiovascular ward.” Jun 2007; 66(2):130-4. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17512633&ordinalpos=29&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum, (9) Keeney D, Ruzin A, Bradford PA. “RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae.” 2007 Spring; 13(1):1-6. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17536927&ordinalpos=27&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum, (10) Kim SH, Wei CI.